Eliem Therapeutics Stock (NASDAQ: ELYM) stock price, news, charts, stock research, profile.
Open | $5.77 |
Close | $6.00 |
Volume / Avg. | 140.12K / 185.57K |
Day Range | $5.65 - $6.02 |
52 Wk Range | 2.35 - 11.55 |
Market Cap | $402.36M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 2.05% |
Days to Cover | 3.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eliem Therapeutics (NASDAQ:ELYM) through any online brokerage.
Other companies in Eliem Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), Altimmune (NASDAQ:ALT), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
Eliem Therapeutics has a consensus price target of $15.00.
The stock price for Eliem Therapeutics (NASDAQ: ELYM) is $6 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Eliem Therapeutics.
Eliem Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Eliem Therapeutics.
Eliem Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.